✦ LIBER ✦
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
✍ Scribed by Gabriele Simonini, Andrea Taddio, Marco Cattalini, Roberto Caputo…
- Book ID
- 120690519
- Publisher
- BioMed Central
- Year
- 2013
- Tongue
- English
- Weight
- 306 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1546-0096
No coin nor oath required. For personal study only.